Syntara LimitedASX: SNT

Quarterly Shareholder Report

· Issued by Syntara Limited

Filed with ASX · · 5 pages · English

Summary by 6ix AI

Syntara ended the quarter with a strong cash position, although it experienced a net cash outflow due to operating activities. The report emphasizes ongoing clinical trials and the company's strategic focus on advancing its drug development pipeline.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Syntara Limited on 6ix

In the deck

Earlier from Syntara

Later from Syntara

All Syntara news releases